Home/Filings/4/0001193125-26-006569
4//SEC Filing

Balcom Alexandra 4

Accession 0001193125-26-006569

CIK 0001861560other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 5:25 PM ET

Size

19.2 KB

Accession

0001193125-26-006569

Insider Transaction Report

Form 4
Period: 2026-01-05
Balcom Alexandra
Chief Financial Officer
Transactions
  • Sale

    Class A Common Stock

    2026-01-05$96.06/sh871$83,66888,279 total
  • Sale

    Class A Common Stock

    2026-01-05$96.85/sh1,119$108,37587,160 total
  • Sale

    Class A Common Stock

    2026-01-05$97.96/sh1,929$188,96585,231 total
  • Sale

    Class A Common Stock

    2026-01-05$98.52/sh317$31,23184,914 total
  • Sale

    Class A Common Stock

    2026-01-06$96.75/sh1,321$127,80783,593 total
  • Sale

    Class A Common Stock

    2026-01-06$97.33/sh1,635$159,13581,958 total
  • Sale

    Class A Common Stock

    2026-01-06$98.40/sh225$22,14081,733 total
  • Award

    Class A Common Stock

    2026-01-07+17,50099,233 total
  • Award

    Stock Option (Right to Buy)

    2026-01-07+17,50017,500 total
    Exercise: $106.82Exp: 2036-01-07Class A Common Stock (17,500 underlying)
Footnotes (10)
  • [F1]The sale was effected pursuant to a durable Rule 10b5-1 sell-to-cover instruction letter entered into on December 6, 2023 to satisfy the reporting person's tax withholding obligations upon the vesting of previously granted equity awards.
  • [F10]The shares underlying this option vest over the four years following January 7, 2026 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.34 to $96.33, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (8) of this Form 4.
  • [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.34 to $97.33, inclusive.
  • [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.34 to $98.33, inclusive.
  • [F5]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.34 to $99.10, inclusive.
  • [F6]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.03 to $97.02, inclusive.
  • [F7]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.03 to $98.02, inclusive.
  • [F8]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.04 to $98.74, inclusive.
  • [F9]Consists of shares of Nuvalent, Inc. Class A Common Stock issuable under restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Nuvalent, Inc. Class A Common Stock. The RSUs vest in three equal annual installments following January 7, 2026, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

Documents

1 file

Issuer

Nuvalent, Inc.

CIK 0001861560

Entity typeother

Related Parties

1
  • filerCIK 0001862147

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 5:25 PM ET
Size
19.2 KB